Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2000; Volume 57,Issue 6

Articles

  • You have access
    A Surface-Exposed Region of Gsα in Which Substitutions Decrease Receptor-Mediated Activation and Increase Receptor Affinity
    Galina Grishina and Catherine H. Berlot
    Molecular Pharmacology June 2000, 57 (6) 1081-1092;
  • You have access
    Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions
    Masanari Itokawa, Zhicheng Lin, Ning-Sheng Cai, Cindy Wu, Shigeo Kitayama, Jia-Bei Wang and George R. Uhl
    Molecular Pharmacology June 2000, 57 (6) 1093-1103;
  • You have access
    Late Endosomal/Lysosomal Targeting and Lack of Recycling of the Ligand-Occupied Endothelin B Receptor
    Alexander Oksche, Gregor Boese, Angelika Horstmeyer, Jens Furkert, Michael Beyermann, Michael Bienert and Walter Rosenthal
    Molecular Pharmacology June 2000, 57 (6) 1104-1113;
  • You have access
    Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating
    Hong Dang, Pamela M. England, S. Sarah Farivar, Dennis A. Dougherty and Henry A. Lester
    Molecular Pharmacology June 2000, 57 (6) 1114-1122;
  • You have access
    Post-Transcriptional Regulation of Bradykinin B1 and B2 Receptor Gene Expression in Human Lung Fibroblasts by Tumor Necrosis Factor-α: Modulation by Dexamethasone
    El-Bdaoui Haddad, Alison J. Fox, Jonathan Rousell, Gillian Burgess, Peter McIntyre, Peter J. Barnes and K. Fan Chung
    Molecular Pharmacology June 2000, 57 (6) 1123-1131;
  • You have access
    Reconstitution of the Human 5-HT1D Receptor-G-Protein Coupling: Evidence for Constitutive Activity and Multiple Receptor Conformations
    Reginald Brys, Katty Josson, Maria Paola Castelli, Mirek Jurzak, Peter Lijnen, Walter Gommeren and Josée E. Leysen
    Molecular Pharmacology June 2000, 57 (6) 1132-1141;
  • You have access
    Coupling of I1 Imidazoline Receptors to the cAMP Pathway: Studies with a Highly Selective Ligand, Benazoline
    Hugues Greney, Philippe Ronde, Céline Magnier, Françoise Maranca, Carla Rascente, Wilma Quaglia, Mario Giannella, Maria Pigini, Livio Brasili, Claire Lugnier, Pascal Bousquet and Monique Dontenwill
    Molecular Pharmacology June 2000, 57 (6) 1142-1151;
  • You have access
    Doxorubicin Impairs Crossbridge Turnover Kinetics in Skinned Cardiac Trabeculae after Acute and Chronic Treatment
    Evert L. de Beer, Antonio E. Bottone, Jolanda van der Velden and Emile E. Voest
    Molecular Pharmacology June 2000, 57 (6) 1152-1157;
  • You have access
    A Repressive Cross-Regulation between Catalytic and Promoter Activities of the CYP1A1 and CYP2E1Genes: Role of H2O2
    Yannick Morel, Isabelle de Waziers and Robert Barouki
    Molecular Pharmacology June 2000, 57 (6) 1158-1164;
  • You have access
    Two Different Signaling Mechanisms Involved in the Excitation of Rat Sympathetic Neurons by Uridine Nucleotides
    Elisa Bofill-Cardona, Nina Vartian, Christian Nanoff, Michael Freissmuth and Stefan Boehm
    Molecular Pharmacology June 2000, 57 (6) 1165-1172;
  • You have access
    Cycloheximide Increases Proenkephalin and Tyrosine Hydroxylase Gene Expression in Rat Adrenal Medulla
    Je-Seong Won, Jin-Koo Lee, Dong-Keun Song, Sung-Oh Huh, Jun-Sub Jung, Yung-Hi Kim, Mi-Ran Choi and Hong-Won Suh
    Molecular Pharmacology June 2000, 57 (6) 1173-1181;
  • You have access
    A Kinetic Binding Study to Evaluate the Pharmacological Profile of a Specific Leukotriene C4 Binding Site Not Coupled to Contraction in Human Lung Parenchyma
    Saula Ravasi, Valérie Capra, Maurizio Mezzetti, Simonetta Nicosia and G. Enrico Rovati
    Molecular Pharmacology June 2000, 57 (6) 1182-1189;
  • You have access
    Identification and Molecular Characterization of Rat CXCR3: Receptor Expression and Interferon-Inducible Protein-10 Binding Are Increased in Focal Stroke
    Xinkang Wang, Xiang Li, Dulcie B. Schmidt, James J. Foley, Frank C. Barone, Robert S. Ames and Henry M. Sarau
    Molecular Pharmacology June 2000, 57 (6) 1190-1198;
  • You have access
    Glycine and γ-Aminobutyric AcidA Receptor Function Is Enhanced by Inhaled Drugs of Abuse
    Michael J. Beckstead, Jeff L. Weiner, Edmond I. Eger, Diane H. Gong and S. John Mihic
    Molecular Pharmacology June 2000, 57 (6) 1199-1205;
  • You have access
    Response Element and Coactivator-Mediated Conformational Change of the Vitamin D3 Receptor Permits Sensitive Interaction with Agonists
    Michaela Herdick, Yvonne Bury, Marcus Quack, Milan R. Uskokovic, Patsie Polly and Carsten Carlberg
    Molecular Pharmacology June 2000, 57 (6) 1206-1217;
  • You have access
    Molecular Basis for Differential Sensitivity of KCNQ and IKs Channels to the Cognitive Enhancer XE991
    Hong-Sheng Wang, Barry S. Brown, David McKinnon and Ira S. Cohen
    Molecular Pharmacology June 2000, 57 (6) 1218-1223;
  • You have access
    Bryostatin 1 Induces Prolonged Activation of Extracellular Regulated Protein Kinases in and Apoptosis of LNCaP Human Prostate Cancer Cells Overexpressing Protein Kinase Cα
    Jürgen E. Gschwend, William R. Fair and C. Thomas Powell
    Molecular Pharmacology June 2000, 57 (6) 1224-1234;
  • You have access
    Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum
    Yutaka Hirata, Norimichi Nakahata and Yasushi Ohizumi
    Molecular Pharmacology June 2000, 57 (6) 1235-1242;
  • You have access
    Inactivation Studies of Acetylcholinesterase with Phenylmethylsulfonyl Fluoride
    Daniel Kraut, Heather Goff, Reetesh K. Pai, Natilie A. Hosea, Israel Silman, Joel L. Sussman, Palmer Taylor and Judith G. Voet
    Molecular Pharmacology June 2000, 57 (6) 1243-1248;
  • You have access
    Importance of Phenylalanine 107 in Agonist Recognition by the 5-Hydroxytryptamine3A Receptor
    Lucinda J. Steward, Frank G. Boess, Joy A. Steele, Dan Liu, Norris Wong and Ian L. Martin
    Molecular Pharmacology June 2000, 57 (6) 1249-1255;
  • You have access
    Nucleotide Modulation of Pinacidil Stimulation of the Cloned KATP Channel Kir6.2/SUR2A
    Fiona M. Gribble, Frank Reimann, Rebecca Ashfield and Frances M. Ashcroft
    Molecular Pharmacology June 2000, 57 (6) 1256-1261;
  • You have access
    Allopregnanolone Synthesis in Cerebellar Granule Cells: Roles in Regulation of GABAA Receptor Expression and Function during Progesterone Treatment and Withdrawal
    Paolo Follesa, Mariangela Serra, Elisabetta Cagetti, Maria Giuseppina Pisu, Stefania Porta, Stefania Floris, Federico Massa, Enrico Sanna and Giovanni Biggio
    Molecular Pharmacology June 2000, 57 (6) 1262-1270;

Erratum

  • You have access
    Correction for Volume 57, p. 188
    Molecular Pharmacology June 2000, 57 (6) 1271;
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 57 (6)
Molecular Pharmacology
Vol. 57, Issue 6
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics